A New Form of Glutamate Signaling Discovered in Migraine – Discovery and  Innovation at University of Utah Health

A New Form of Glutamate Signaling Discovered in Migraine – Discovery and Innovation at University of Utah Health

4.9
(71)
Écrire un avis
Plus
€ 34.99
Ajouter au panier
En Stock
Description

Beyond the role of glutamate as a neurotransmitter

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo

Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert - ScienceDirect

62nd Annual Scientific Meeting American Headache Society® - 2020 - Headache: The Journal of Head and Face Pain - Wiley Online Library

63rd Annual Scientific Meeting American Headache Society® - 2021 - Headache: The Journal of Head and Face Pain - Wiley Online Library

Frontiers Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs

Pharmacological targeting of glutamatergic neurons within the brainstem for weight reduction

A New Form of Glutamate Signaling Discovered in Migraine – Discovery and Innovation at University of Utah Health

63rd Annual Scientific Meeting American Headache Society® - 2021 - Headache: The Journal of Head and Face Pain - Wiley Online Library

The International Headache Congress – IHS and EHF joint congress 2021, The Journal of Headache and Pain

Targeting glutamate signalling in depression: progress and prospects

PDF) Questioning Glutamate Excitotoxicity in Acute Brain Damage: The Importance of Spreading Depolarization

Frontiers Pathophysiological Ionotropic Glutamate Signalling in Neuroinflammatory Disease as a Therapeutic Target

Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders

IJMS, Free Full-Text